These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12396278)

  • 1. Urinary excretion of selegiline N-oxide, a new indicator for selegiline administration in man.
    Katagi M; Tatsuno M; Tsutsumi H; Miki A; Kamata T; Nishioka H; Nakajima K; Nishikawa M; Tsuchihashi H
    Xenobiotica; 2002 Sep; 32(9):823-31. PubMed ID: 12396278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of selegiline-N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry.
    Katagi M; Tatsuno M; Miki A; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):125-33. PubMed ID: 11499616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of selegiline, R-methamphetamine, R-amphetamine, and desmethylselegiline in oral fluid after a single oral administration of selegiline.
    Chen L; Shen B; Wang S; Yu Y; Yan H; Shi Y; Duan G; Xiang P
    Drug Test Anal; 2019 Jun; 11(6):898-905. PubMed ID: 30614204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users.
    Nishida K; Itoh S; Inoue N; Kudo K; Ikeda N
    J Anal Toxicol; 2006 May; 30(4):232-7. PubMed ID: 16803660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
    Slawson MH; Taccogno JL; Foltz RL; Moody DE
    J Anal Toxicol; 2002 Oct; 26(7):430-7. PubMed ID: 12422997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites.
    Shin HS
    Drug Metab Dispos; 1997 Jun; 25(6):657-62. PubMed ID: 9193866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of deprenyl metabolites.
    Lengyel J; Magyar K; Hollósi I; Bartók T; Báthori M; Kalász H; Fürst S
    J Chromatogr A; 1997 Feb; 762(1-2):321-6. PubMed ID: 9098991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy.
    Hasegawa M; Matsubara K; Fukushima S; Maseda C; Uezono T; Kimura K
    Forensic Sci Int; 1999 Apr; 101(2):95-106. PubMed ID: 10371041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of Methamphetamine Abuse and Selegiline Use： Chiral Analysis of Methamphetamine and Amphetamine in Urine].
    Xiang P; Bu J; Qiao Z; Zhuo XY; Wu HJ; Shen M
    Fa Yi Xue Za Zhi; 2017 Dec; 33(6):599-603. PubMed ID: 29441766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.
    Mascher HJ; Kikuta C; Millendorfer A; Schiel H; Ludwig G
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):9-13. PubMed ID: 9021435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
    Dirikolu L; Lehner AF; Karpiesiuk W; Hughes C; Woods WE; Boyles J; Harkins JD; Troppmann A; Tobin T
    Vet Ther; 2003; 4(3):257-68. PubMed ID: 15136987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system.
    Rohatagi S; Barrett JS; DeWitt KE; Lessard D; Morales RJ
    Biopharm Drug Dispos; 1997 Nov; 18(8):665-80. PubMed ID: 9373724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of enantiomeric metabolites of l-deprenyl, d-methamphetamine, and racemic methamphetamine in urine by capillary electrophoresis: comparison of deprenyl use and methamphetamine use.
    Kim EM; Chung HS; Lee KJ; Kim HJ
    J Anal Toxicol; 2000; 24(4):238-44. PubMed ID: 10872569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas-chromatographic study on the stereoselectivity of deprenyl metabolism.
    Tarjányi Z; Kalász H; Szebeni G; Hollósi I; Báthori M; Fürst S
    J Pharm Biomed Anal; 1998 Aug; 17(4-5):725-31. PubMed ID: 9682156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine and amphetamine derived from the metabolism of selegiline.
    Romberg RW; Needleman SB; Snyder JJ; Greedan A
    J Forensic Sci; 1995 Nov; 40(6):1100-2. PubMed ID: 8522918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine.
    Maurer HH; Kraemer T
    Arch Toxicol; 1992; 66(9):675-8. PubMed ID: 1482291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro confirmation of selegiline N-oxidation by flavin-containing monooxygenase in rat microsome using LC-ESI MS.
    Tsutsumi H; Katagi M; Nishikawa M; Tsuchihashi H; Kasuya F; Igarashi K
    Biol Pharm Bull; 2004 Oct; 27(10):1572-5. PubMed ID: 15467197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding.
    Laine K; Anttila M; Huupponen R; Mäki-Ikola O; Heinonen E
    Clin Neuropharmacol; 2000; 23(1):22-7. PubMed ID: 10682227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.
    Heinonen EH; Anttila MI; Karnani HL; Nyman LM; Vuorinen JA; Pyykkö KA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):602-9. PubMed ID: 9243353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.